Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Mary Alexis Iaccarino, M.D.

Concepts (103)

Back to Profile
Concepts are derived automatically from a person's publications.
The timeline below shows the dates (blue tick marks) of publications associated with Mary Iaccarino's top concepts. The average publication date for each concept is shown as a red circle, illustrating changes in the primary topics that Mary Iaccarino has written about over time.
Myofascial Pain Syndromes, 1 publications between 2014 and 2014, average publication date March 2014. Hemianopsia, 1 publications between 2017 and 2017, average publication date March 2017. Magnetic Field Therapy, 1 publications between 2017 and 2017, average publication date March 2017. Methylphenidate, 1 publications between 2018 and 2018, average publication date March 2018. Post-Concussion Syndrome, 1 publications between 2018 and 2018, average publication date May 2018. Education, 1 publications between 2019 and 2019, average publication date March 2019. Nervous System Diseases, 2 publications between 2018 and 2020, average publication date May 2019. Athletic Injuries, 3 publications between 2019 and 2019, average publication date June 2019. Attention Deficit Disorder with Hyperactivity, 3 publications between 2018 and 2020, average publication date July 2019. Brain Injuries, 4 publications between 2015 and 2023, average publication date August 2019. Brain Concussion, 14 publications between 2018 and 2023, average publication date February 2020. Accidents, Traffic, 2 publications between 2019 and 2021, average publication date November 2020.

To see the data from this visualization as text, click here.
Iaccarino's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (103)
Explore
_
Co-Authors (27)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
© 2024 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.